SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr Reddys Lab’s Q3 consolidated net surges 88%

03 Feb 2012 Evaluate

Dr Reddys Laboratories has reported results for third quarter ended December 31, 2011.

The company has posted a fall of 58.89% in its net profit of Rs 108.03 crore for the quarter ended December 31, 2011 as compared to Rs 262.77 crore for the same quarter in the previous year. However, total income has increased by 14.36% from Rs 1426.97 crore for Q3FY11 to Rs 1631.86 crore in the quarter under review.

On the consolidated basis, the group has posted 87.80% surge in its net profit to Rs 512.96 crore for the quarter ended December 31, 2011 as compared to Rs 273.14 crore in the same quarter last year. Total income of the company improved by 46.52% to Rs 2752.71 crore for the quarter compared to Rs 1878.72 crore in the quarter, year ago.

Dr. Reddys Lab Share Price

1315.85 -17.20 (-1.29%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×